Cancer
Half of cancers diagnosed at late stage
September 22, 2014Research and Development, Sales and Marketing CRUK, Cancer, NHS, UK, oncology
A Cancer Research UK study out today reveals that nearly half of all cancers in England are diagnosed at an …
‘Angelina effect’ sees BRCA tests soar in UK
September 19, 2014Medical Communications, Research and Development, Sales and Marketing Cancer, angelina jolie, brac1, brad, breast, mastectomy
Referrals for testing for breast cancer risk more than doubled across the UK, after Oscar-winning American actress Angelina Jolie announced …
GSK melanoma drug sees quick NICE nod
September 18, 2014Sales and Marketing Cancer, GSK, NICE, Tafinlar, Yervoy, dabrafenib, melanoma, skin cancer
NICE is recommending GlaxoSmithKline’s new melanoma treatment Tafinlar (dabrafenib) after the firm offered a discount for its medicine. In final …
Cancer drug gains first early UK access grant
September 17, 2014Research and Development, Sales and Marketing Cancer, NICE, UK, keytruda, oncology, pin, promising
A new type of cell therapy for cancer has become the first to be deemed by the UK government as …
Celgene rebuffed by NICE over cancer drug
September 9, 2014Sales and Marketing Abraxane, Cancer, Celgene, Gemzar, NICE, gemcitabine, nab-paclitaxel
In new draft guidance NICE says that Celgene’s Abraxane (nab-paclitaxel) taken with Lilly’s Gemzar (gemcitabine) should not be funded by …
NHS cancer services not holding up, says report
September 8, 2014Research and Development, Sales and Marketing CRUK, Cancer, NHS, UK, government, oncology
NHS cancer services are in urgent need of investment and review, according to a new report commissioned by Cancer Research …
Merck surprise winner in PD-1 race
September 5, 2014Medical Communications, Research and Development, Sales and Marketing Cancer, Merck, melanoma, pd-1
Merck has become the first company to bring a new class of cancer drug to the US market after the …
NICE: Cancer Drugs Fund must use our processes
September 3, 2014Medical Communications, Research and Development, Sales and Marketing CDF, Cancer, David Haslam, Kadcyla, NICE, Roche
NICE believes that the Cancer Drugs Fund should be aligned with its cost-effectiveness processes, after the government recently announced a …
Children’s cancer death rates drop
September 2, 2014Medical Communications, Research and Development, Sales and Marketing CRUK, Cancer, Cancer Research UK, child, death rates
The rate of children dying from cancer has dropped by 22% in the last decade, according to new data published …
NHS proton beam therapy refusal led to child patient disappearance
September 1, 2014Sales and Marketing Ashya King, Cancer, NHS, proton beam
The parents of child cancer patient Ashya King say they took him from hospital because NHS doctors would not offer …
Roche pays $8.3bn for InterMune
August 26, 2014Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Genentech, IPF, Illumina, InterMune, Roche
Roche has stumped up $8.3 billion in cash to pay for US biotech firm InterMune and will gain access to …
Top four cancer killer rates ‘fall by a third’
August 18, 2014Research and Development, Sales and Marketing CRUK, Cancer, bowel, charity, lung, prostate, research
Death rates for breast, bowel, lung and prostate cancer combined have fallen by almost a third in the last 20 …
Charities ‘disappointed’ in NICE and Janssen
August 15, 2014Sales and Marketing Cancer, Janssen, NHS, NICE, Zytiga, prostate
The Institute of Cancer Research and Prostate Cancer UK are both urging NICE and Janssen to ‘get their act together’ …
Amgen cancer drug fails key test
August 14, 2014Sales and Marketing Amgen, Cancer, Kyprolis, myeloma
Amgen’s new rare cancer drug has failed in a late-stage trial just a year after the US biotech spent $10.4 …
Cancer Research UK appeals for clarity on Wikipedia
August 13, 2014Medical Communications, Sales and Marketing Cancer, Cancer Research UK, wikimania, wikipedia
Cancer Research UK is calling upon the medical community to become more involved with Wikipedia to ensure better accuracy of …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
ESTEVE CDMO adds $17.5m to Illinois expansion
